Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

American College of Radiology urges FDA to address breast biopsy needle shortages
“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.
Bill in Congress would rein in PBMs, force divestment from pharmacies
The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.
‘Best Countries’ report: Middling scores for health cut into US’s bid for overall greatness
A meticulous comparison of quality-of-life factors across 100 countries has yielded good news and bad news for the United States of America.
Blood pressure drug recalled after failed test
Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.
CMS pauses new Medicare hospice and home health provider entries for six months
The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.

American College of Radiology urges FDA to address breast biopsy needle shortages

“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.

Bill in Congress would rein in PBMs, force divestment from pharmacies

The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.

‘Best Countries’ report: Middling scores for health cut into US’s bid for overall greatness

A meticulous comparison of quality-of-life factors across 100 countries has yielded good news and bad news for the United States of America.

Blood pressure drug recalled after failed test

Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.

CMS pauses new Medicare hospice and home health provider entries for six months

The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.

Consolidation of physician practices proceeds apace, corporatizing medicine one acquisition at a time

The days when most doctors worked in independent practice settings are fading from memory like old photoprints in a musty scrapbook.

Video: Samuel Jones, MD, MPH, FACC, director of Inpatient Electrophysiology at the Memorial Hospital for Chattanooga Heart Institute, and co-chair of the American College of Cardiology (ACC) and Heart Rhythm Society (HRS) guidance For electrophysiology ablation in ambulatory surgical centers (ASCs), explains the details of this shift in cardiology care delivery.

Key points to remember when performing cardiac ablations in ASCs

When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.

Siemens Healthineers nabs FDA clearance for 6 new IR systems

Siemens Healthineers scores FDA clearance for 6 interventional systems

Each device comes equipped with a new AI feature designed to deliver high quality imaging at lower radiation doses during IR procedures.